1. Home
  2. PD vs KTTA Comparison

PD vs KTTA Comparison

Compare PD & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PagerDuty Inc.

PD

PagerDuty Inc.

HOLD

Current Price

$12.87

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$1.15

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PD
KTTA
Founded
2009
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
5.3M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
PD
KTTA
Price
$12.87
$1.15
Analyst Decision
Buy
Strong Buy
Analyst Count
10
1
Target Price
$17.70
$3.00
AVG Volume (30 Days)
3.2M
21.6M
Earning Date
11-25-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.63
N/A
Revenue
$489,207,000.00
N/A
Revenue This Year
$8.21
N/A
Revenue Next Year
$4.33
N/A
P/E Ratio
$7.98
N/A
Revenue Growth
7.01
N/A
52 Week Low
$11.13
$0.28
52 Week High
$20.57
$3.85

Technical Indicators

Market Signals
Indicator
PD
KTTA
Relative Strength Index (RSI) 41.28 59.11
Support Level $11.55 $1.09
Resistance Level $13.30 $1.32
Average True Range (ATR) 0.48 0.23
MACD 0.12 0.01
Stochastic Oscillator 80.92 40.76

Price Performance

Historical Comparison
PD
KTTA

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Share on Social Networks: